NASDAQ: LICNLichen International Ltd Stock
$2.82+0.31 (+12.35%)
Updated Jun 12, 2026
LICN Price
$2.82
Fair Value Price
N/A
Market Cap
$46.04M
52 Week Low
$0.75
52 Week High
$9.49
P/E
-0.69x
P/B
0.65x
P/S
0.61x
PEG
N/A
Dividend Yield
N/A
Revenue
$24.52M
Earnings
-$21.96M
Gross Margin
37.3%
Operating Margin
-89.58%
Profit Margin
-89.6%
Debt to Equity
0.07
Operating Cash Flow
-$18M
Beta
1.23
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
LICN Overview
Lichen International Ltd. is a company that delivers a range of services, encompassing financial and tax advice, educational assistance, and the provision of software alongside its maintenance. Established on April 13, 2016, by founder Li Ya, the firm operates from its main office in Jinjiang, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine LICN's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Business Service
Industry Rating
C
LICN
Ranked#27 of 31
Ranked#27 of 31
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.59 | A | |
| $52.52 | B | |
| $150.89 | B |
Be the first to know about important LICN news, forecast changes, insider trades & much more!
LICN News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how LICN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
LICN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LICN is good value based on its book value relative to its share price (0.65x), compared to the US Specialty Business Services industry average (3.64x)
P/B vs Industry Valuation
LICN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more LICN due diligence checks available for Premium users.
Valuation
LICN fair value
Fair Value of LICN stock based on Discounted Cash Flow (DCF)
Price
$2.82
Fair Value
-$4.60
Undervalued by
161.26%
LICN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
LICN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.69x
Industry
28.76x
Market
14.15x
LICN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.65x
Industry
3.64x
LICN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
LICN's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
LICN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
LICN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$75.6M
Liabilities
$5.0M
Debt to equity
0.07
LICN's short-term assets ($36.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LICN's short-term assets ($36.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LICN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LICN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
LICN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
LICN vs Specialty Business Service Stocks
Lichen International Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.